136 related articles for article (PubMed ID: 6576383)
1. Experimental studies on the possible combined chemotherapy to neoplasms with Fluosol-DA infusion.
Ohyanagi H; Nishijima M; Usami M; Nishimatsu S; Matsui E; Saitoh Y
Prog Clin Biol Res; 1983; 122():315-20. PubMed ID: 6576383
[TBL] [Abstract][Full Text] [Related]
2. [Fluosol-DA in extracorporeal circulation - an experimental study (author's transl)].
Ozono H; Taira A; Toyohira H; Higashi T; Yamashita M; Shimokawa S; Umebayashi Y; Saigenji H; Hamada Y; Arikawa K; Akita H
Kyobu Geka; 1981 Oct; 34(10):776-80. PubMed ID: 7311221
[No Abstract] [Full Text] [Related]
3. [Possibility of the use of perfluorochemicals (fluorocarbons) as adjuvants in chemotherapy of cancer].
Kuwamura K; Kokunai T
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1256-61. PubMed ID: 7184453
[TBL] [Abstract][Full Text] [Related]
4. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
5. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
[TBL] [Abstract][Full Text] [Related]
6. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
Teicher BA; Holden SA; Jacobs JL
Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
[TBL] [Abstract][Full Text] [Related]
7. The effect of Fluosol-DA on pulmonary vessels.
Nishimura N; Sugi T; Hiranuma N
Prog Clin Biol Res; 1983; 122():283-9. PubMed ID: 6878371
[TBL] [Abstract][Full Text] [Related]
8. Fluosol-DA as a red-cell substitute in acute anemia.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
[TBL] [Abstract][Full Text] [Related]
9. Oxygenated fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function.
Jaffe CC; Wohlgelernter D; Highman HA; Cleman M
Prog Clin Biol Res; 1986; 211():21-7. PubMed ID: 2938192
[No Abstract] [Full Text] [Related]
10. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
[TBL] [Abstract][Full Text] [Related]
11. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
[TBL] [Abstract][Full Text] [Related]
12. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
Kim GE; Song CW
Cancer Chemother Pharmacol; 1989; 25(2):99-102. PubMed ID: 2513138
[TBL] [Abstract][Full Text] [Related]
13. [Experimental studies on the effect of perfluorochemicals in tumor irradiation].
Shinoda J; Iwai T; Hattori T; Kondo H; Sakai N; Yamada H
Gan No Rinsho; 1984 Jan; 30(1):53-8. PubMed ID: 6700116
[TBL] [Abstract][Full Text] [Related]
14. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
Ishikawa R; Peerless SJ; Hunter IG
No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
Teicher BA; Bernal SD; Holden SA; Cathcart KN
Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with Fluosol-DA.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
[TBL] [Abstract][Full Text] [Related]
17. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
Kokunai T; Kuwamura K
No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
[TBL] [Abstract][Full Text] [Related]
18. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
Teicher BA; Herman TS; Holden SA; Cathcart KN
Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033
[TBL] [Abstract][Full Text] [Related]
19. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
Kessler M; Vogel H; Günther H; Harrison DK; Höper J
Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
[No Abstract] [Full Text] [Related]
20. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
Oda Y; Handa H; Nagasawa S; Naruo Y; Asato R; Yonekawa Y
Neurol Res; 1982; 4(1-2):35-45. PubMed ID: 6127644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
